EquityFlow › Companies › Enara Bio

Enara Bio

Biotech · Oxford, GB

Developing Dark Antigen-based cancer immunotherapies.

Funding history

DateRoundAmount
Oct 2024Series B
Enara Bio, an Oxford cancer-immunotherapy biotech, raised a $32.5M Series B co-led by Pfizer Ventures and M Ventures.
$32.5M

Investors

M VenturesPfizer Ventures

Similar companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca
Explore funding flow on EquityFlow →